Zdrowie i gospodarka · 13/01/1998

FDA Announces Comment Period for Cholestin TM Regulatory Status

The FDA is accepting comments on the regulatory status of Cholestin TM until January 30, 1998, as part of its deliberation on the matter, with all comments postmarked by this date being part of the official record.